After a stellar performance in November — following a poor show in October — the new business premium (NBP) of life insurance companies was largely flat in December. This is owing to a 20 per cent fall in Life Insurance Corporation’s (LIC) NBP.
However, in the October-December quarter (Q3), NBP of life insurers jumped 10.45 per cent over the same period last year, mainly backed by the robust growth of private insurers’ NBP.
In Q3 of FY22, insurers earned NBP to the tune of Rs 73,249.97 crore, compared to Rs 66,318.76 crore earned in the same period last year. While private insurers’ NBP grew by 33 per cent, LIC’s NBP contracted by 2.6 per cent. NBP is the premium acquired from new policies for a particular year.
In December, private insurers’ NBP rose 30 per cent year-on-year (YoY) to Rs 13,032.33 crore, surpassing that of LIC at Rs 11,434.13 crore. LIC’s NBP dipped 20 per cent largely due to a 35 per cent fall in group single premium.
Among large private life insurers, NBP of HDFC Life reported 56 per cent YoY growth, while SBI Life saw 27 per cent growth, and Max Life reported 32 per cent growth. ICICI Prudential, on the other hand, reported a 6 per cent dip in NBP for December.
In Q2 of FY22, Indian insurers netted NBP to the tune of Rs 75,392 crore, up 16 per cent from the same period last year. LIC’s NBP was up 14 per cent to Rs 51,488 crore and private insurers’ NBP was up 20 per cent to Rs 23,904.2 crore.
The April-June quarter (Q1 of FY22) was marred by pandemic-induced lockdowns and NBP of life insurers had plummeted more than 18 per cent.
So far, in the current financial year (first nine months), life insurance companies reported NBP to the tune of Rs 2.05 trillion, up 7.43 per cent YoY from the year-ago period. Private insurers recorded 30 per cent growth.
But LIC’s NBP is in the red. In the first nine months of the financial year, LIC’s NBP was Rs 1.26 trillion, down 3.07 per cent.
The current quarter (January-March) is perhaps the best period for life insurers in terms of business because people tend to buy greater pure-risk and savings products for tax-saving purposes.
Further, with Covid-19 cases rising rapidly again, demand for pure protection products may spike once again. Demand for pure protection products was expected to be muted, given the price hike insurers are taking on their term products, on the prodding of the global reinsurer. But the rapid rise in infections may just offset the price impact.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU